Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers

Diabetologia

Volumn 40, Issue 10, 1997, Pages 1211-1218

  Cominacini, L ^a,c   Young, M M R ^b   Capriati, A ^b   Garbin, U ^a   Fratta Pasini, A ^a   Campagnola, M ^a   Davoli, A ^a   Rigoni, A ^a   Confessi, G B ^a   Lo Cascio, V ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Antioxidant; Atherosclerosis; LDL; LDL oxidation; Lipid hydroperoxides; Non insulin dependent diabetes mellitus

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; TROGLITAZONE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; ANTIOXIDANTS; CHROMANS; HUMANS; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; REFERENCE VALUES; THIAZOLES; THIAZOLIDINEDIONES; TIME FACTORS; TRIGLYCERIDES;

EID: 9844230954     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050809     Document Type: Article

References (44)

1. Ciaraldi TP, Gilmore A, Olefsky JM (1990) In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 39: 1056-1062
2. Fujiwara T, Yoshioca S, Yoshioca T (1988) Characterization of new oral antidiabetic agent CS-045. Diabetes 37: 1549-1555
3. Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T (1996) Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 19: 151-156
4. Kumar S, Boulton AJM, Beck-Nielsen H et al. (1996) Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia 39: 701-709
5. Steiner C (1985) Atherosclerosis, the major complication of diabetes. Adv Exp Med Biol 189: 277-297
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 14: 915-924
7. Esterbauer H, Jurgens G, Quehenberger O, Koller E (1987) Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 28: 495-509
8. Cominacini L, Garbin U, Davoli A et al. (1991) A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res 32: 349-358
9. Regnstrom JN, Nilsson J, Tornavall P, Landou C, Hamsten A (1992) Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339: 1183-1186
10. Cominacini L, Garbin U, Pastorino M et al. (1993) Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 99: 63-70
11. Cominacini L, Pastorino AM, Garbin U et al. (1994) The susceptibility of LDL to in vitro oxidation is increased in hypercholesterolemic patients. Nutrition 10: 527-531
12. Cominacini L, Garbin U Pastorino AM et al. (1994) Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Diab Res 26: 173-184
13. Mao SJ, Yates MT, Rechtin AE, Jackson RI, Van Sickle WA (1991) Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J Med Chem 34: 298-302
14. Cominacini L, Garbin U, Cenci B et al. (1991) Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to alpha-tocopherol content in humans. Clin Chim Acta 204: 57-68
15. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H (1991) Effect of oral supplementation with alphatocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32: 1325-1332
16. Babiy AV, Gebicky JM, Sullivan DR (1992) Increased oxidazibility of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochem Pharmacol 43: 995-1000
17. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA Willet WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328: 1450-1456
18. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC (1993) Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 328: 1444-1449
19. Noguchi N, Sakai H, Kato Yet al. (1996) Inhibition of oxidation of low density lipoprotein by troglitazone. Atherosclerosis 123: 227-234
20. Cominacini L, Garbin U, Pastorino AM et al. (1997) Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper ions and endothelial cells. Diabetologia 40: 165-172
21. Cominacini L, Zocca I, Garbin U et al. (1988) Long-term effect of a low-fat, high-carbohydrate diet on plasma lipids of patients affected by familial endogenous hypertriglyceridemia. Am J Clin Nutr 48: 57-65
22. Havel RJ, Eder MA, Bragdon JM (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353
23. Smith PK, Krohn RI, Hermanson GT et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 105: 293-299
24. Lehmann J, Martin HL (1982) Improved direct determination of alpha- and gamma-tocopherol in plasma and platelets by liquid chromatography with fluorescence detection. Clin Chem 28: 1345-1353
25. Cominacini L, Garbin U, Fratta Pasini A et al. (1997) Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Rad Biol Med 22: 117-127
26. Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in one-step reaction. J Lipid Res 26: 114-118
27. Sata T, Havel RJ, Jones AL (1972) Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res 18: 465-471
28. Cominacini L, Garbin U, Fratta Pasini A et al. (1995) Susceptibility to in vitro oxidation of LDL derived from patients at risk for atherosclerosis: relation to LDL subfraction profile. In: Bellomo GFG, Finardi G, Maggi E, Rice-Evans C (eds) Free radicals, lipoprotein oxidation and atherosclerosis. Richelieu Press, London, pp 473-492
29. Sasahara M, Raines EW, Chait A et al. (1994) Inhibition of hypercholesterolemia-induced atherosclerosis in the non-human primate by probucol. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest 94: 155-164
30. Princen HMG, Van Poppel G, Vogelezang C, Buytenhek R, Kok FJ (1992) Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoproteins from lipid peroxidation in vitro. Arterioscler Thromb 12: 554-562
31. Esterbauer H, Rotheneder M, Striegl G et al. (1989) Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sei Technol 91: 316-324
32. Austin MA, Breslow JL, Hennekens CH, Buring JE, Wilet WC, Krauss RM (1988) Low density lipoprotein subclass pattern and risk of myocardial infarction. JAMA 260: 1917-1921
33. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Denmarker PNM, Hendriks JCM, Stalenhoef AFH (1991) Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscl Thromb 11: 298-308
34. Kleinveld HA, Naber AHJ, Stalenhoef AFH, Denmarker PNM (1993) Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Rad Biol Med 15: 273-280
35. Wang T, Yu W, Powell WS (1992) Formation of monohydroxy derivatives of arachidonic acid, linoleic acid, and oleic acid during oxidation of low density lipoprotein by copper ions and endothelial cells. J Lipid Res 33: 525-535
36. Yoshida Y, Niki E (1992) Oxidation of methyl linoleate in acqueous dispersions induced by copper and iron. Arc Biochem Biophys 295: 107-114
37. Thomas CE, Jackson RL (1991) Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins. J Pharm Expt Ther 256: 1182-1189
38. Patsch JR, Miesenhock G, Hopferwieser Tet al. (1992) Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arteriosclerosis Thromb 12: 1336-1345
39. McNamara JR Jenner JL, Li Z, Wislon PWF, Schaefer EJ (1992) Change in LDL particle size is associated with change in plasma triglyceride concentration. Arteriosclerosis Thromb 12: 1284-1290.
40. Miyazawa T, Fujimoto K (1990) Determination of lipid hydroperoxides in low density lipoproteins from human plasma using high performance liquid chromatography with chemiluminescent detection. Biomed Chromat 4: 131-134
41. Cominacini L, Pastorino AM, McCarthy A et al. (1993) Determination of lipid hydroperoxides in native low density lipoprotein by a chemiluminescent flow-injection assay. Biochim Biophys Acta 1165: 279-287
42. Zamburlini A, Maiorino M, Barbera P et al. (1995) Measurement of lipid hydroperoxides in plasma lipoproteins by a new highly-sensitive "single photon counting" luminometer. Biochim Biophys Acta 1256: 233-240
43. Pastorino AM, Cominacini L, Maiorino M et al. (1994) Effect of plasma on the degradation of hydroperoxides of unesterified linoleic acid and copper-peroxidized LDL. Free Rad Biol Med 16: 459-463
44. Niki E (1987) Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 44: 227-253